주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-19 17:10 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
642 )
기사목록 보기 형태
제목형
요약형
포토형
Junior doctors worldwide urge Seoul to stop punitive measures against Korean colleagues
Kim Ju-yeon
2024.04.09 14:58
Government to review proposal to postpone med student increase for 1 year: vice minister
Kwak Sung-sun
2024.04.08 15:24
'Japanese model of med school enrollment, regional quota system might be a lesson for Korea'
Kim Eun-young
2024.04.08 13:38
Novartis' rare disease drug Ilaris passes health insurance review panel
Kim Yun-mi
2024.04.05 14:23
Liver expert calls for Seoul to conduct Hepatitis C testing for all Koreans
Kim Yun-mi
2024.04.04 16:19
Patient support group, physicians fight multiple myeloma together
Lee Han-soo
2024.04.04 09:30
Government fills medical void by allowing telemedicine for public health centers
Kwak Sung-sun
2024.04.03 15:35
Korea to allow terminal patients to stop life-sustaining treatment more flexibly
Kwak Sung-sun
2024.04.03 12:49
President Yoon nails down his push to increase medical school admission quota by 2,000 seats
Lee Han-soo
2024.04.01 15:06
Korea to boost funding for surgeries on severely ill children by up to 1,000%
Kwak Sung-sun
2024.03.29 15:56
ILO calls for Seoul to resolve medical turmoil through social dialogue
Kim Ju-yeon
2024.03.29 13:02
Regulator warns against purchasing health supplements from overseas
Yang Hyeon-su
2024.03.29 11:15
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기